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Abstract
Aim: To report a protocol for a qualitative study to better understand the key factors 
that influence decision making about pregnancy from women's perspectives and to 
use these data to develop a theoretical model for shared decision- making tools for 
the multiple stakeholders.
Design: Mixed- method design using online surveys (with validated components) and 
purposively sampled follow- up semi structured interviews.
Methods: Funded from September 2020 for 12 months. Online surveys of adult 
women (aged 18– 50) identified via all Wales kidney database (n ≥ 500), additional 
recruitment through multidisciplinary healthcare professionals, relevant third sector 
organizations and social media. Follow- up in- depth qualitative interviews with n = 30 
women. Linear regression models to identify associations between shared decision- 
making preferences and clinical and psychosocial variables. Qualitative interviews will 
use a visual timeline task to empower women in taking control over their narratives. 
Qualitative data will be fully transcribed and analysed thematically, based around a 
chronological and theoretical (theoretical domains framework) structure that maps 
out key challenges and opportunities for improved decision support in the care path-
way. Visual timelines will be used during stakeholder consultation activities, to en-
able us to co- create a map of current support, gaps in provision, and opportunities 
for interventions. Quantitative data will be analysed descriptively to characterize our 
cohort. We will assemble a multidisciplinary shared decision- making intervention de-
velopment group and provide ongoing stakeholder consultation activities with patient 
and public representatives.
Discussion: Outcomes will support new learning into; the ways women's knowledge 
of kidney disease may affect family planning and pregnancy, their needs in terms of 
psychological and social support, and how they weigh up the pros and cons of start-
ing a family.
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1  |  INTRODUC TION
An estimated 195 million women are affected by kidney disease world-
wide. (‘2018 WKD Theme - World Kidney Day’, n.d.) Recent research 
increasingly highlights that many aspects of kidney disease have spe-
cific gender disparities (Bikbov et al., 2018; Goldberg & IIan, n.d.; Iseki, 
2008; Nature Publishing Group, 2018; Piccoli et al., 2018). Differences 
in global healthcare systems, culture, socio economics, attitudes and 
values have led to a global call to action for new research which puts 
these contradictions into their respective contexts (Bikbov et al., 
2018). Decisions about pregnancy and the challenges pregnancy can 
bring while living with kidney disease is one such difference and unique 
to women. Clinical nurse specialists from nephrology, transplantation, 
gynaecology, obstetrics and midwifery work with multidisciplinary 
teams (MDTs) to provide care, information and support to women with 
kidney disease who are considering pregnancy. Recent research in de-
veloped countries has focussed on learning more about experiences 
of care and support from the women's perspectives and found among 
other things, an unhelpful focus on clinical perspectives of risk, and 
importantly a need for new shared decision- making interventions to 
support patients and professionals with the complex and often emo-
tional decisions which need to be made about pregnancy while living 
with kidney disease (Jesudason & Tong, 2019; Tong et al., 2015).
2  |  BACKGROUND
The presence of maternal chronic kidney disease (CKD) is well- 
recognized to be associated with adverse pregnancy outcomes, and 
medical management of these women during the course of their 
pregnancy can be challenging. The risks to both the mother and baby 
increase steeply with declining kidney function, in particular for 
those with CKD stage 4 or 5, on dialysis or with a kidney transplant.
Globally more than 3 million people are currently receiving renal 
replacement therapy (RRT), with this projected to rise to 5.5 mil-
lion by 2030 (Renal Registry UK, 2015). More women have kidney 
disease than men, yet more men are on a renal replacement ther-
apy. Gender disparities such as this are becoming increasingly ap-
parent within the global kidney population (Antlanger et al., 2019). 
Approximately 5% of Australian women of childbearing age have 
albuminuria or abnormal eGFR (AIHW, 2014). In England, an esti-
mated 2.5% of women in the 35– 54 age group have CKD stage 3– 5, 
putting them at increased risk of pregnancy- related complications 
such as pre- eclampsia (Public Health England, 2014). Wales is part 
of the United Kingdom with a devolved healthcare system and a 
population of around 3 million (Wales Population Database, 2020). 
The prevalence of CKD rises with age and the number of births to 
mothers aged 35 and over in Wales is also steadily increasing (Welsh 
Government, n.d.). The need to engage and support women of re-
productive age with CKD with decisions about pregnancy and fam-
ily planning is a necessary cornerstone of providing high- quality 
patient- centred care in CKD (Jesudason & Tong, 2019).
Decisions about pregnancy are complex and emotive, and for 
women with CKD, pregnancies need to be carefully planned and mon-
itored. Some medications used by CKD patients can be teratogenic 
and may need to be stopped or changed well in advance of pregnancy. 
There is a significant risk that pregnancy will lead to an irreversible de-
cline in kidney function, a risk that increases with the baseline severity 
of disease (Blom et al., 2017). The risk of preterm delivery is significantly 
greater for women with CKD 4 and 5 (89% of births at <37 weeks) and 
is often accompanied by intra- uterine growth retardation.
Qualitative studies indicate that effects of pregnancy on long- 
term renal health, and of CKD on pregnancy outcomes, are major 
concerns for women with CKD (Tong et al., 2015a, 2015b). Women 
report ‘decisional conflict’ surrounding family planning and express 
a need for ‘control and determination’ over their choices (Tong et al., 
2015b). Patient- health professional relationships can affect physical 
health outcomes for women who give birth after a renal transplant, 
as this forms an important component of the social support that 
women receive (Yoshikawa et al., 2018).
Shared decision making is an approach where clinicians and pa-
tients share the best available evidence and patients are supported 
to consider their options and preferences (Elwyn et al., 2012). 
Shared decision making can help patients make more informed de-
cisions aligned with their personal preferences, become more active 
and empowered in their own healthcare, have better relationships 
with their healthcare professionals and feel more satisfied with their 
choices (Foundation, 2012). Preconception decision aids for women 
with rheumatoid arthritis, multiple sclerosis (Prunty et al., 2008) and 
epilepsy (McGrath et al., 2017) have been found to increase wom-
en's knowledge about pregnancy and their disease and reduce deci-
sional uncertainty.
2.1  |  Rationale
There are significant gaps in the evidence on the childbearing- 
related information needs of women with non- communicable 
Impact: Evidence will inform the design of new shared decision- making tools to bet-
ter support women with the complex and often emotional decisions about having 
children while living with kidney disease.
K E Y W O R D S
kidney disease, mixed- methods, nursing, pregnancy, protocol, shared decision- making, women
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diseases (Holton et al., 2012) and the effectiveness of interven-
tions to improve outcomes for women with disabilities who are 
starting a family and their children (Malouf et al., 2014). Qualitative 
research on shared decision making has been identified as a high 
priority area in the latest Renal Association Clinical Practice 
Guideline on Pregnancy and Renal Disease (Wiles et al., 2019).
This study will address an important gap in the evidence base 
by clarifying how women of reproductive age who have CKD make 
decisions about pregnancy, and how this relates to their health, 
well- being and pregnancy outcomes. These data will form part of a 
systematic process of developing a preconception shared decision- 
making intervention to facilitate informed and preference- sensitive 
discussions between clinicians, specialist nurses, women with CKD 
and their families about reproductive choices.
Implementing shared decision making during the pre- conception pe-
riod with women who have CKD has the potential to improve the quality 
of decisions made about their care, helping avoid potential disadvan-
tages to many women with CKD and their families (Elwyn et al., 2012).
2.2  |  Theoretical framework
This is a mixed- methods study using surveys and depth qualita-
tive interviews with women aged 18– 50 living with CKD across 
the United Kingdom. We will apply a combination of the behaviour 
change wheel (BCW) (Figure 1) and the theoretical domains frame-
work (TDF) (Figure 2) to support any designs and evaluations of be-
haviour change interventions and policies resulting from the study 
(Richardson et al., 2019).
Combined these frameworks will enable us to design new 
patient- centred shared decision- making interventions (including 
who does what, when and where), map these onto wider health and 
social contexts, and identify areas in health and psycho/social care 
where interventions are (a) needed and (b) most likely to work and to 
replicate them in future.
Theoretically informed behaviour change interventions are es-
pecially important in kidney health and social care as the system is 
very complex: large MDTs (including social workers, psychologists, 
dieticians, pharmacists, occupation therapists, specialist nurses, 
renal registrars and renal consultants) are tasked with long- term pa-
tient care. These MDTs work closely with kidney charities and wider 
social service providers. Women who are making decisions about 
pregnancy, or are pregnant will also consult with obstetrics and 
gynaecology specialists. Women who have kidney failure will also 
need to make decisions about their future treatment (e.g., dialysis 
and transplant) in addition to pregnancy options and choices.
The TDF and BCW provide a comprehensive eight- stage process 
to intervention design (a) define the problem, (b) select the target be-
haviour, (c) specify the target behaviour and identify (d) what needs 
to change, (e) intervention functions, (f) policy categories, (g) be-
haviour change techniques (BCTs) and (h) mode of delivery (Cowdell 
& Dyson, 2019). The framework(s) are suitably robust and flexible 
enough to underpin theoretical modelling in the complex system of 
kidney health and social care.
3  |  THE STUDY
3.1  |  Aim(s)
To improve support for women with kidney disease with the com-
plex choices they need to make in relation to pregnancy by:
1. Identifying needs and preferences of women of reproductive 
age with kidney disease by improving our understanding of 
how women make decisions about pregnancy, and investigating 
associations between pregnancy, health, well- being and psy-
chosocial contexts
2. Constructing a theoretical model for decision making in rela-
tion to pregnancy, an essential first step in the development of a 
F I G U R E  1  The Behaviour Change 
Wheel, adopted from Michie, et al. ‘The 
behaviour change wheel: A new method 
for characterizing and designing behaviour 
change interventions’.
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1. carry out an online survey of women of reproductive age living 
in the United Kingdom who have kidney disease to understand 
women's information needs, decision- making preferences, pri-
orities and psychosocial context regarding their own health, 
well- being and healthy pregnancies.
2. obtain consent to follow- up from women completing the online sur-
vey, with a view to establishing a longitudinal cohort that will enable 
us to prospectively investigate long- term health and well- being out-
comes for women with kidney disease and their children in the future.
3. use in- depth qualitative interviews to understand women's lived ex-
periences and develop a theoretical model of how women make deci-
sions about pregnancy using the TDF and BCW (Michie et al., 2011).
4. carry out a variety of stakeholder consultation activities to identify 
opportunities in the current care pathway to introduce enhanced 
support with decision making based on women and MDTs expe-
rience and knowledge of services already available in Wales for 
women with kidney disease (e.g. preconception counselling) and 
establish which types of decision support tools are preferred by 
women and MDTs (e.g. value clarification exercises, option grids).
5. Facilitate recruitment into the UK- wide Rare Renal Registry (RaDaR, 
rarerenal.org) in parallel with this work to help improve the availability 
of high- quality evidence to inform women and MDTs in the future.
3.3  |  Design/Methodology
This is a mixed- method study adopting a convergent design to data 
collection and analysis (Figure 3) (Noyes, Booth, et al., 2019). This will 
include an online survey of women of reproductive age using kidney 
services across Wales (n ≥ 500), in- depth qualitative interviews with 
F I G U R E  2  Theoretical Domains Framework cited from Cowdell, et al. ‘How is the theoretical domains framework applied to developing 
health behaviour interventions? A systematic search and narrative synthesis’.
F I G U R E  3  Recruitment to survey systems and services.
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up to 30 women of reproductive age who have kidney disease and 
ongoing stakeholder consultation activities with patient and public 
representatives and a multidisciplinary intervention development 
group. Shared decision making in practice is highly complex incor-
porating consideration of a patient's clinical history, lifestyle, social 
circumstances and preferences (Elwyn et al., 2012). As such, we will 
follow the Medical Research Council guidance on developing and 
evaluating complex interventions (Craig et al., 2008; Skivington et al., 
2018) and the International Patient Decision Aid Standards (IPDAS) 
guidelines (Coulter et al., 2013; Elwyn et al., 2009). This study will 
correspond to the ‘modelling’ phase of the MRC guidance and the 
scoping, steering and design (components 1 and 2) stages of the 
IPDAS guidance on developing decision aids (Coulter et al., 2013; 
Craig et al., 2008).
3.4  |  Pan- Wales survey of women of reproductive 
age with kidney disease
The online self- report survey (FORM D) will provide us with cross- 
sectional baseline data for a population of women of reproductive 
age with kidney disease to enable us to understand their decision- 
making processes, lived experiences, and health and well- being out-
comes relating to pregnancy. The survey will also allow us to apply 
a purposive sampling framework to recruit women for the in- depth 
qualitative interviews, as well as establish a cohort of women of 
reproductive age who have kidney disease, which will provide an 
opportunity for prospective longitudinal data to be collected in the 
future.
3.4.1  |  Participants and setting
Inclusion criteria
All women with kidney disease, or who are on dialysis, or have a 
transplant aged between 18– 50 and living in the United Kingdom 
will be eligible to participate in this study. As a Wales led study the 
primary focus and settings will be in Wales, and at this stage, focus 
on the Welsh perspective. In Wales approximately 5000 women 
aged 18– 50 are in secondary kidney care and will attend clinics 
at one of the following three health boards; Swansea Bay, Betsi 
Cadwaladr and Cardiff and Vale which cover five sites across Wales 
(Cardiff, Swansea, Wrexham, Bangor and Glan Clwyd).
Exclusion criteria
- Women under 18 and over 51.
- Women who live outside the United Kingdom
- Men
Measures
The survey (FORM D) will include questions on current treatment 
for kidney disease (drop down list); renal function (eGFR); years since 
diagnosis of kidney disease; current medication (drop down list); 
co- morbidities (open text) and family situation (currently pregnant, 
planning to try to get pregnant, and/or had a pregnancy, had children 
already, and if so, how many and what their ages are). Demographic 
data will be collected on age, highest educational qualification, geo-
graphical location (postcode), marital/relationship status, ethnicity 
and current employment status. The survey will also assess infor-
mation needs in relation to pregnancy and family planning, prefer-
ences for shared decision making relating to pregnancy (Autonomy 
Preference Index), and open questions relating to current experi-
ences of shared decision making, gaps in provision and preferences 
for decision support.
Procedure
The self- report survey will be completed online using the Bristol 
Online Survey system. Recruitment for the online survey will take 
place using a multi- pronged approach (Figure 4) including publicising 
the survey pan- Wales via nephrology clinics, social media (Twitter 
and Facebook), and patient- facing organizations (e.g., Kidney 
Research UK, Paul Popham Foundation, Kidney Wales). The in-
formed consent process will be completed online prior to commenc-
ing the survey (FORM C) and include an email cover letter (FORM 
A) and Participant Information Sheet (PIS) (FORM B). Women who 
have taken part in the survey will be asked for consent to contact 
in the future to invite them to take part in qualitative interviews 
and follow- up surveys. We will also signpost to the Registry of Rare 
Kidney Diseases (RaDaR). All patient facing materials will be pro-
duced bilingually.
Recruitment and identification
Figure 3 provides an overview of the systems and services we will 
connect with to promote and distribute the survey. The design fo-
cuses on women currently in secondary care in Wales, but is suit-
ably flexible to include women with, for example early stage kidney 
disease and women in England who may be alerted via social media 
or word of mouth. This is important as we have found from previ-
ous research, it is common for people to reside in Wales and receive 
treatment in England and vice versa. A key part of this study is also 
to promote The National Registry of Rare Kidney Diseases (RaDaR), 
a UK wide database and open to eligible UK citizens.
We will recruit through:
1. VitalData, the renal database in use in all Welsh units.
2. The kidney MDTs, for example consultants, specialist nurses, psy-
chologists, social workers and other key members of the MDTs in 
Wales.
3. Kidney unit staff and managers. There are currently 18 dialy-
sis units across Wales. Units provide bespoke communications 
(newsletters, updates, social media groups) to individuals who 
dialyse in their units. We will approach unit managers and staff 
to share the survey invitation via email, face- to- face communica-
tions and posters visibly on display.
4. Renal Charity Partners. All kidney charities in the United Kingdom 
have been informed about this study and form part of the steering 
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committee (see steering committee section) these include, Paul 
Popham Renal Fund (Wales), Kidney Wales (Wales), Kidney Care 
UK (UK) and Polycystic Kidney Disease Charity UK (UK). We will 
approach kidney charities to advertise the survey through their 
channels and networks, including social media and mailing lists.
5. Wider Charities. We will approach several national charities in-
cluding; Diabetes Cymru, Diabetes UK, British Heart Foundation 
and SANDS (stillbirth and neonatal death) Charity UK to distrib-
ute an invitation for those who are eligible to take part.
6. Online forums. We will promote the study through online social 
forums such as Netmums, MumsNet, Reddit, Facebook and local 
social media groups (MDTs and charity partners will support us to 
identify local groups).
Sample size
Based on population analysis, there are approximately 5,000 women 
in Wales aged between 18– 50 who have CKD or had a transplant. 
For the planned regression analysis, we require at least 120 par-
ticipants. This will enable us to carry out analysis of multiple vari-
ables associated with information needs based on Green's (Green, 
1991) rule of thumb of n = 104 + m for regression analysis assessing 
the effect of individual predictors on continuous outcomes, where 
m is the number of variables entered into the model. However, we 
also seek to characterize this population, collect longitudinal data 
in the future, and investigate the potential for linking data from 
our cohort to RaDaR for future analysis. Given the timeframe and 
resources available for the current study, we will aim to recruit at 
least 500 women into our cohort. By using VitalData and publicly 
available data via the Renal Registry, we will be able to assess an 
approximated response rate and describe any key differences in dis-
ease profiles/demographics/geographical area that could have an 
impact on the generalizability of our sample. We plan to continue 
building this cohort beyond the scope of the current study. Due to 
the use of the online survey methodology, there is potential to ex-
tend this work to target under- represented groups identified during 
our initial analysis, and to open the survey out across the United 
Kingdom and internationally in future phases of this research at lit-
tle additional cost.
Survey data analysis
Analysis of the quantitative data will be carried out using SPSS.v.27. 
Analysis will be primarily descriptive, providing an overview of the 
clinical and demographic characteristics of our sample, and their 
well- being, shared decision- making preferences and information 
needs. To identify differences in self- reported pregnancy and health 
outcomes according to key clinical and demographic factors, inde-
pendent t- tests will be carried out, and 95% confidence intervals 
will be calculated. Between- group differences in support received/
desired, which will be coded as binary categorical variables, will be 
tested for using chi- square. The Holm– Bonferroni correction (Sture, 
1979) for multiple comparisons will be used to adjust the alpha level 
to allow for multiple comparisons. Multivariable regression analysis 
will be used to identify variables that are independently associated 
with levels of information needs and shared decision- making prefer-
ences to identify groups that may be in need of additional or tailored 
support. Open text data from the survey will be coded thematically 
using an inductive approach to identify frequent, dominant and sig-
nificant themes that emerged from the data (Thomas, 2006).
F I G U R E  4  Study flow chart and diagram.
    |  7PHILLIPS et aL.
3.4.2  |  Qualitative interviews with women 
with CKD
Kidney disease can impact on fertility and pregnancy outcomes and 
may alter the planned timing of a pregnancy. For example, women 
with declining function or on dialysis may elect to postpone preg-
nancy until they have received a kidney transplant. The experience 
of organ failure or organ donation can in itself change women's 
attitude to pregnancy, for example due to feelings of fear, guilt or 
shifting priorities. These aspects are unique to kidney disease and 
women's attitudes to these are poorly understood in the UK popula-
tion and will be explored through qualitative interviews. Their need 
for decision support tools will be explored.
Participants and sampling
We will interview up to 30 women with kidney, about their lived 
experiences and shared decision- making preferences, purposively 
sampled from survey participants who have provided consent to 
contact. The maximum variation sampling framework will ensure 
that a range of views are represented, including from those with 
‘average’, ‘below average’ or ‘above average’ kidney disease burden 
based on the survey scores, and those who have and have not al-
ready had a pregnancy/pregnancies. The qualitative sample size and 
approach to sampling has been determined on the basis of providing 
sufficient information power to answer the research questions for 
this component of the study (Malterud et al., 2016).
Interview procedure
Informed consent (FORM E, consent for interview) will be sought 
before interviews take place. The qualitative interviews will be fa-
cilitated using a visual timeline (FORM F, Interview guide and time-
line) (Goldenberg et al., 2016). The use of participatory approaches 
such as timelines in qualitative research can empower participants 
by allowing them to navigate the conversation, increase their level of 
comfort in discussing sensitive topics, provide positive moments and 
opportunities for closure (Goldenberg et al., 2016; Kolar et al., 2015). 
Members of our team have successfully used this method in both 
face- to- face and telephone interviews with women with autoim-
mune rheumatic diseases to discuss pregnancy planning, pregnancy 
and early parenting, eliciting rich narratives (Phillips et al., 2018; 
Williams et al., 2019).
Interviews will be carried out in a COVID safe way (see COVID 
update below). Before the interviews, women will be sent a resource 
pack, which will include stationary, a timeline template, and exam-
ples of the themes that we are interested in covering during the 
interview (FORM F, interview guide and timeline). Timelines will pro-
vide a visual tool to enable women to map out their journey towards 
starting a family, noting key events and their physical and emotional 
responses to these.
Qualitative data analysis
Interviews will be audio- recorded and transcribed verbatim. Data 
will be analysed thematically using a hybrid approach of inductive 
and deductive analysis based on social phenomenology (Fereday & 
Muir- Cochrane, 2006). NVivo will be used to facilitate analysis. The 
coding framework will be built around the TDF (Michie et al., 2011) 
(Figure 2
) to enable us to develop a theoretical model of decision- making 
relating to pregnancy and provide a strong conceptual foundation 
for the design of a shared decision- making intervention. We will use 
regular qualitative research team meetings to discuss data produc-
tion, development of the coding framework and data analysis, with 
each member of the qualitative research group adding their unique 
perspective to the analysis (Barbour, 2001).
3.5  |  Overarching convergent data integration
We will use a matrix approach to data integration (O’Cathain et al., 
2010) in order to look in depth at individual cases across different 
types of data (survey and interviews), the relationships within and 
between datasets, and to identify the key patterns and tendencies 
across all of the data. This will enable us to create a better under-
standing of women's lived experiences and at the same time develop 
the overall theoretical model.
3.6  |  Timescale and milestones
We will complete this study within 12 months. Our timescale for the 
study is set out below and summarized in Figure 4. ‘Study flow chart 
and diagram’.
Months −6 to 0: Study set up
1. Obtain favourable approvals before the study commences
2. Contracting and staff recruitment
3. Establish a stakeholder reference group
Month 1– 6: Online survey and qualitative data collection.
Months 3 to 10: Qualitative survey and interview data coding 
and analysis.
Months 2 to 8: Quantitative survey data analysis.
Months 6– 12: Development of the theoretical model for shared 
decision making in this context.
Months 9– 12. Write- up, dissemination of findings, and planning 
for future research (Figure 4).
3.7  |  Ethical considerations
We have received Research Ethics Committee approval (Registered 
REC Number: 20/WA/0157) Informed written consent is required 
for participants to take part. We attach the following participant in-
formation documents: FORM A Cover Letter; FORM B participant 
information sheet; FORM C Consent form survey; FORM D the 
online survey; FORM E consent form interview; FORM F Interview 
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topic guide and timeline; and FORM G Poster for recruitment, as 
online supplemental files (Data S1).
3.7.1  |  Specific ethical considerations for this study
This is a low- risk study undertaking surveys and interviews with 
adults. Nonetheless some of the topics covered are sensitive, for 
example complicated pregnancies, miscarriages, stillbirths and be-
reavement. We have produced an ‘Ethical Considerations, Practical 
strategies and Distress Protocol (Data S2). This is a modified proto-
col which we have successfully used in previous studies with acutely 
bereaved participants (Noyes, Mclaughlin, et al., 2019).
We have also partnered with Stillbirths And Neonatal Death 
Charity (SANDS) and provide links and contact details to this charity, 
as well as kidney disease charities, and relationship counselling char-
ities (Relate) at the end of the survey. Research officers conducting 
this study have long term experience undertaking research in these 
areas and are trained to be mindful of the appropriate times to pause 
or stop collecting data. Interviewers will sign post to the additional 
support charities and services at the end of each interview, in case 
participants would like to access free support and counselling out-
side of a NHS context.
3.8  |  Validity, reliability and rigour
The study has been awarded funding via a competitive funding 
stream (British Renal Society and Kidney Care UK research fund-
ing call) and subject to high- quality, independent expert peer review. 
Validated tools have been adopted for use in the survey (Decision 
self- efficacy scale, CollaboRATE, Autonomy Preference Scale) 
(Elwyn et al., 2013; Morandi et al., 2017; Ottawa Hospital, 2018). 
We will use the four- dimension criteria (credibility, dependability, 
confirmability and transferability) in the interview processes and 
subsequent analysis (Forero et al., 2018). The MDT will bring their 
individual expertise to the interpretation of interview transcripts 
and agree key findings and messages. The results- based convergent 
design will ensure all outcomes are integrated and synthesized to 
address the overall study aims (Noyes, Booth, et al., 2019). Reporting 
will follow agreed international standards to ensure transparency 
from the EQUATOR network (Network, n.d.).
3.8.1  |  Stakeholder consultation activities
Our multidisciplinary intervention development group includes ex-
perts in nephrology, specialist nursing, obstetrics, clinical and health 
psychology, shared decision making, and development and evalua-
tion of complex interventions. Through our professional networks, 
we will carry out a variety of stakeholder consultation activities, in-
cluding one- to- one meetings and visits to MDTs and patient groups 
to exchange knowledge.
3.8.2  |  Steering committee
The core research team includes MDT of health psychologists, social 
workers, nephrologists, health and social care scientists, and patient 
representatives. We have recruited additional representatives from the 
following: consultant gynecologists; patient representatives; shared 
decision- making experts; CEO of the Paul Popham Renal Fund; lead 
counsellor Paul Popham Renal Fund, CEO of Kidney Wales; advocacy of-
ficer Kidney Care UK; representatives from Stillbirth and neonatal death 
charity (SANDs); Clinical Lecturers in Renal Sciences (Kings College 
London, Department Women and Children's Health) and the Welsh 
Renal Clinical Network (commissioners of renal services in Wales). We 
will continue to recruit suitable representatives to the steering commit-
tee as appropriate and will communicate with the committee through-
out via emails, face- to- face and virtual meetings with specific groups and 
people. We will also host an interim steering committee meeting with the 
whole group. This meeting will provide independent views on progress 
to date and expertise and input shaping the reminder of the study— in 
particular the theoretical modelling— and future research planning.
3.8.3  |  Patient and public involvement
Contribution to research development
The original intellectual ideas for the research emerged from consul-
tations with women with kidney disease who as individuals, partners, 
mothers and carers articulated that they faced complex decision mak-
ing about pregnancy and their personal health and well- being. This 
grant was developed in partnership with three women living with kid-
ney disease all of whom have faced challenges in making decisions 
about pregnancy. We also undertook informal consultancy with a 
group of eight patients who are volunteer ‘befrienders’ at the Paul 
Popham Foundation. All of the group felt that the research addressed 
an important gap in understanding women's needs, values and expec-
tations in terms of pre- and post- natal psychosocial care and support.
Involvement and participation throughout the study
This study is examining lived experiences of women with CKD and 
their decision making around pregnancy. The topic is complex and 
highly emotive. We anticipate that women who take part in this re-
search will be particularly interested in the research outcomes and 
shared decision- making tools. We will encourage active participa-
tion throughout by creating opportunities to share learning and for 
patients to feed into the research such as creating a patient refer-
ence group, invitation to attend data analysis meetings across, pres-
entations at patient group meetings, and opportunities to co- present 
research and co- write academic articles.
3.9  |  Dissemination of research
We will work with our patient co- applicant and stakeholders to pro-
duce public facing summaries of our findings, which will be distributed 
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via social media, and the renal charities and national research centres 
and groups. This will include newsletters, plain English summaries 
of progress and findings, and an infographic summarising the main 
findings of the study. To facilitate adoption of patient- centred care 
and shared decision making throughout the NHS, we will share our 
findings in other long- term condition forums (e.g., organ transplant 
groups, rheumatology, diabetes), where similar complex decisions 
around starting families are faced by patients and their families.
An impact case study will be created on the Wales Kidney 
Research Unit webpage and we will present at their annual meet-
ing. We will connect with Welsh renal charities and present findings 
at their meetings. We will present our work at the UKKW confer-
ence, NHS Research and Development conferences, and MDT 
team meetings to share our findings and demonstrate the benefits 
of multidisciplinary research and coproduction with patient groups.
Outputs will include
1. baseline demographic, clinical and psychosocial data from a 
cohort of women of reproductive age with kidney disease in 
Wales, with consent to follow- up contact so that longitudinal 
data can be collected prospectively in future research;
2. theoretical model of the way in which women make decisions 
about pregnancy and family planning, by applying the TDF to the 
analysis of the survey and interview qualitative data;
3. at least two publications in peer- reviewed journals (baseline 
survey data, shared decision- making intervention development 
paper);
4. a lay summary, infographic and brief video clip for patients and 
members of the public.
Following up the work
Having identified needs and developed a model of shared decision 
making for women with CKD in relation to pregnancy, we will need 
to move to the next stage of development of the shared decision- 
making intervention; developing a prototype and alpha testing. This 
study will provide the basis for future funding applications led by the 
co- applicants (e.g., BRS/KCUK, the MRC Public Health Intervention 
Development scheme, NIHR) for pilot testing, refinement of the 
intervention, and subsequent rigorous evaluation of its implemen-
tation in UK clinical practice. We will also seek to build on the on-
line survey cohort as the programme of work picks up momentum, 
and we will explore opportunities for data linkage with RaDaR and 
routinely collected data in systems such as Secure Anonymised 
Information Linkage (SAIL) databank.
4  |  DISCUSSION
This study was awarded funding in January 2020 and was set up 
during the COVID- 19 pandemic. We undertook an assessment of 
any impact to the study should movement continue to be restricted 
Many of the study processes and procedures were only designed for 
virtual sharing in the first instance, for example the survey is online 
only. The one to one interviews can be completed over the phone or 
via a web app and the preparation documents (FORM F) can be sent 
via the post— or virtually if the person to be interviewed feels com-
fortable completing the timelines on a home computer. The remain-
der of the processes including MDT engagement can be completed 
via the various online networks and forums which have been set up 
as a result of COVID- 19. Charities and partners have fast tracked 
several online communication networks and forums (e.g., Facebook 
and twitter chats and coffee morning) all of which will only benefit 
the recruitment and engagement of participants with this study. We 
have already found that due to social distancing many people living 
with kidney disease are seeking more active and meaningful activi-
ties they can participate in while shielding— which they may need to 
do (as kidney patients) depending on current guidance and individual 
clinical recommendations. We do not believe that future potential 
restrictions on movement will have any significant impact on the de-
livery of the study.
4.1  |  Limitations
The study primarily focuses on Welsh participants. Younger adults, 
for example 16– 18 are excluded from this sample as are older par-
ticipants over 51. BAME perspectives are likely to be low as Wales 
has a predominately white population. We are unable to include in-
terviews and focus groups with professionals due to time and re-
source restrictions.
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